A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 227.46% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 48.76%. Over the past 30 days, the price of ATYR has fallen by 2.88%. And in the last five days, it has fallen by -4.61%.
The current stock price for Atyr Pharma Inc (ATYR) is $5.37. The stock experienced a significant increase during the last trading session, reaching $35.0 after opening at $5.39. It dipped to a low of $9.0 before ultimately closing at $5.71.
The market performance of Atyr Pharma Inc has been somewhat stable.
52-week price history of ATYR Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Atyr Pharma Inc’s current trading price is -16.61% away from its 52-week high, while its distance from the 52-week low is 239.90%. The stock’s price range for this period has been between $1.58 and $6.44. The Healthcare sector company’s shares saw a trading volume of about 2.79 million for the day, which was higher than the average daily volume of 2.62 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Atyr Pharma Inc (ATYR) has experienced a quarterly rise of 63.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 477.99M and boasts a workforce of 59 employees.
Expert Opinions: Analysts’ Ratings for Atyr Pharma Inc
As of right now, 7 analysts are rating Atyr Pharma Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
ATYR’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ATYR stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.16.
ATYR Stock Stochastic Average
As of today, the raw stochastic average of Atyr Pharma Inc over the last 50 days is at 100.00%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 100.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 89.57% and 88.17%, respectively.
